HEPATECELLULAR CARCINOMA
Clinical trials for HEPATECELLULAR CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new HEPATECELLULAR CARCINOMA trials appear
Sign up with your email to follow new studies for HEPATECELLULAR CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental pill SHY-ONC6 takes on Hard-to-Treat cancers
Disease control Recruiting nowThis early-stage trial tests an experimental oral drug called SHY-ONC6 in people with advanced or metastatic solid tumors (including breast, colon, lung, pancreatic, and others) that have stopped responding to standard treatments. The study aims to find a safe dose and check for …
Matched conditions: HEPATECELLULAR CARCINOMA
Phase: PHASE1 • Sponsor: SHY Therapeutics • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
New cocktail therapy targets tough liver cancer with blood clot
Disease control Recruiting nowThis study tests a combination of an experimental immunotherapy (QL1706), a blood vessel blocker (bevacizumab), and chemotherapy given directly into the liver artery for people with advanced liver cancer that has caused a clot in the main portal vein. The goal is to see if this a…
Matched conditions: HEPATECELLULAR CARCINOMA
Phase: PHASE2 • Sponsor: Nanfang Hospital, Southern Medical University • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
AI tool aims to predict liver cancer return after surgery
Knowledge-focused Recruiting nowThis study is testing an artificial intelligence (AI) model to see if it can predict whether early-stage liver cancer will come back within two years after surgery. About 353 adults with early-stage liver cancer will have standard surgery and then be monitored with scans. Their m…
Matched conditions: HEPATECELLULAR CARCINOMA
Sponsor: Tongji Hospital • Aim: Knowledge-focused
Last updated Jun 26, 2026 13:19 UTC